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1. Introduction 
It is well known that bilirubin passes from blood to 
bile by a selective process, which is common to other 
organic anions such as steroids, drugs, bromosul- 
phonphthalein (BSP), Indocyanin Green (ICG), Rose 
Bengal and so on. This process moreover is very rapid: 
5 min after the injection of radioactive bilirubin, 63% 
of the dose is found in the liver, of which 75% is re- 
covered in the supernatant [1,2]. The same phenom- 
enon occurs for BSP and ICG, but not for albumin 
[3]. Recently [4] the presence of intrahepatic pro- 
teins (Y and Z), which display high affinities for bili- 
rubin and other organic anions, has been demonstrated. 
This finding has led Arias [5] to assume that the up- 
take of these substances was strictly correlated with 
the two proteins. He assesses more precisely that the 
process was dependent on 'the amount and binding" 
affinity of albumin in plasma, and the amount and 
binding affinities of Y and Z in the cytoplasm. Influx 
is largely determined by dissociation of anion from 
protein in blood and nonionic diffusion across the 
plasma membrane of the liver cell' [5]. From data 
reported in literature [6,7] it may be calculated that 
the absolute amount of bilirubin inside the liver is 
approximately twice as much as that in the plasma. 
The concentration difference should be higher [7]. 
This is of course not the free bilirubin concentration. 
In fact, both in the plasma nd in the liver the bulk of 
the bilirubin must be bound to albumin and to Y and 
Z respectively. It may be calculated from the total 
amount of albumin and the dissociation constant of 
the bilirubin-albumin complex that the concentration 
of free bilirubin in the plasma is lower than 10 -8 M. 
No data however, are available concerning free 
bilirubin concentration i side the liver cell. 
In order to investigate the mechanism of bilirubin 
uptake across the liver cell plasma membrane, we 
studied the binding affinity Of BSP both to plasma 
proteins and liver cell sap. We decided to use BSP be- 
cause it behaves very similar by to bilirubin with re- 
spect o blood clearance and excretion. We chose to 
use crude fractions (total serum and cytosol) rather 
than purified components o better simulate physio- 
logical conditions. 
2. Materials and methods 
Serum and liver from Wistar rats were used. Serum 
was prepared in the usual way and stored at -20°C 
until used. Livers were perfused in situ immediately 
after sacrifice with ice-cold saline solution through the 
hepatic veins, until all traces of blood were removed. 
All the following operations were performed at 0°C. 
The liver was then removed, weighed and suspended in
0.25 M sucrose containing 0.01M phosphate buffer, 
i 
pH 7.4 according to Levi et al. [4]. Homogenization 
Was carried out at 33% w/v with a motor-driven 50ml 
Potter homogenizer quipped with a Teflon pestle. 
This suspension was immediately spun down in a 
Spinco ultracentrifuge at 105 000 g for 120 min. The 
pellet was discarded, and the supernatant, after re- 
moval of the lipid layer, was kept at -20°C until 
used. 
Protein contents of serum and liver supernatant 
were determined by biuret reaction according to 
Gornall et al~ [8]. Bromosulphonphthalein sodium 
was obtained from DADE (USA). Gel filtration 
chromatography of the supernatant was carried out 
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Fig. 1. BSP binding to proteins hown by flow dialysis. Flow 
rate was 60ml/hr, and time coUection 12 min per tube. See 
text for details. 
in a cold room using a Sephadex G-75 column, equili- 
brated in 0.01 M phosphate buffer, pH 7.4. About 3.5 
ml of supernatant (100 mg protein), brought o room 
temperature, were added to 5.9 nM BSP and kept at 
25°C for 5 min. This material was loaded on to the 
column and eluted with the above mentioned buffer. 
BSP binding capacity was tested by means of conti- 
nuous flow dialysis, essentially according to Colowick 
and Womack [9]. The system consists of two super- 
imposed chambers, separated by a Kalle dialysis mem- 
brane preincubated overnight in 0.295/aM BSP. Both 
chambers are stirred• The upper part of the cell con- 
tains 2 ml of 0.01 M phospahte buffer, pH 7.4, and 
the protein sample. Into this compartment increasing 
BSP additions were made, starting from 0.147/aM and 
reaching 2.094/aM. A continuous flow was maintained 
in the lower chamber (0.1 ml) by an LKB Perpex 
pump, using the above-mentioned buffer. The concen- 
tration of the anion in the effluent from the lower 
chamber was measured spectrophotometrically t 580 
nm after alkalinization. Values obtained were propor- 
tional to the free anion in the upper cell. A suitable 
blank, devoid of protein, was run under the same con- 
ditions. Fig. 1 shows the curves obtained in a typical 
experiment, from which we can calculate, at each 
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Fig• 2. Elution profile from Sephadex G-75 (3 cm x 46 cm) of ratqiver supernatant (60 mg protein)• Elution with 0.01M phos- 
phate buffer pH 7.4, at a flow rate of 360 drops/hr. Each tube contained 4.5 ml. Proteins were followed at 280 nm, and protein- 
linked BSP, after alkalinization, at580 nm 
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Fig. 3. Scatchard plot of BSP binding to rat-serum proteins. 
Protein content 10 mg in 0.01 M phosphate buffer, pH 7.4. 
addition of BSP, the percentage of free BSP, its actu- 
al concentration and the BSP bound per mg of pro- 
tein. These results were plotted by the graphical 
method of Scatchard [10]. The experimental values 
were fitted by least Squares using a computer. 
3. Results and discussion 
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Fig. 4. Scatchard plot of BSP binding to rat-liver supernatant 
proteins. Protein content 20 mg in 0.01 M phosphate buffer, 
pH 7.4, containing 0.25 M sucrose. 
The presence in the supernatant o f  the organic 
anions binding proteins Y and Z was demonstrated by 
the elution profile from Sephadex G-75, shown in fig. 
2. This result c o_rIelat~_extremely w~ll wi_'th the find_- __ ~ i_s the first study carried out on liveLsupernatapt 
ings already presented by Levi et al. [4]. 
Fig. 3 is a Scatchard plot of  BSP binding to rat 
serum. Clearly, two classes of affinity binding sites 
are present, one with high and the other with low 
affinity. The nmoles of BSP bound per mg of protein 
are 60 and 155 respectively. Dissociation constants 
derived from the graph are 0.031 × 10 -6  and 
0.363 × 10 -6 M for the high and low affinity sites 
respectively. These data are in good agreement with 
data reported in literature for the affinity constants 
of rat serum albumin (K 1 = 1.7 X 107 andK 2 = 
1.4 × 106) [5]. It may be calculated from these data 
that the binding capacity of serum may be entirely 
accounted for by its albumin content. 
Fig. 4 shows the BSP binding capacity of rat-liver 
supernatant. In this case two classes of binding sites 
are also present. Binding sites with high affinity bound 
50 nmoles of BSP per mg protein and those with low 
affinity bound 136 nmoles of BSP per mg protein. 
Dissociation constants calculated are 0.075 × 10 -6 
and 0.470 X 10 -6 M respectively. As far as we know, 
as a whole, from the point of  view of BSP binding 
capacity. 
Table 1 summarizes the results obtained from a 
set of  five experiments. In each of them the two dis- 
sociation constants were calculated both for serum 
and liver supernatant taken from the same rat. The 
mean values ~ the standard eviation, were calculated 
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Table 1 
Dissociation constants (/~M) of the two classes of binding sites 
for BSP of rat serum and rat liver supernate at 100 000 g. 
Exp. K1 Serum K1 Super- K2 Serum K2 Super- 
nate nate 
1 0.003 0.066 0.047 2.500 
2 0.010 0.037 0.220 0.480 
3 0.035 0.147 0.580 0.940 
4 0.031 0.075 0.363 0.470 
Mean 0.019-+0.015 0.081±0.047 0.302-+0.225 1.10±0.96 
P <0.05 <0.05 
Pool 0.015 0.150 0.250 0.890 
for each constant. For both K 1 and K 2 the differences 
between serum and supernatant are statistically signi- 
ficant, with p values less than 0.05. Serum and super- 
natant derived from the two series of  experiments 
were pooled, and the values of the two constants once 
again measured. One can see that a difference of one 
order of magnitude is found for K 1 and little less for 
K 2. The most interesting feature emerging from these 
data is the significant difference between dissociation 
constants of serum and liver supernatant, indicating a
higher binding affinity for BSP of serum protein, than 
of the supernatant. For the high affinity binding ca- 
pacities of the two fractions, we can calculate from 
the number of nmoles of BSP bound per mg of pro- 
tein the total capacity for whole serum and liver su- 
pernatant. I f we assume that in the rat there is ap- 
proximately 10 ml of serum (containing 800 mg pro- 
teins) [11] and about 6 g of  liver (containing 330 mg 
of soluble proteins) [12, 13], we obtain for the high 
affinity sites 48 nmoles of BSP bound to serum and 
16.5 nmoles of BSP bound to liver supernatant. I f  we 
make the same calculation for the low affinity bin- 
ding sites, we find 124 nmoles and 44.9 nmoles of 
BSP bound to serum and supernatnat proteinsrespecti- 
vely. Hence the total amount of BSP bound to serum 
is 172 nmoles and 61.4 nmoles to supernatant. From 
these data we can note that the binding capacity of the 
proteins present on the outerside of the liver cell 
plasma membrane is about three-fold higher than that 
found on its inner side. The flux of organic anions 
from plasma to the liver by diffusion can be explained 
only by assuming a higher affinity of  liver proteins 
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than of serum proteins for the anion. From our data 
this not so, we find exactly the opposite: a higher af- 
finity on the outer than on the inner side. Hence it 
is difficult on this basis to support he hypothesis 
that the transfer of  organic anion from plasma into 
the liver occurs by nonionic diffusion across the 
plasma membrane. If, in fact, the total binding capac- 
ity and the affinity constant for BSP is higher in 
serum than in the supernatant, a negative gradient 
will be established across the liver cell plasma mem- 
brane. The simplest explanation of our data would be 
the existence of a carrier-mediated process at the level 
of the plasma membrane. The hypothesis of  simple 
passive nonionic diffusion across the barrier is clearly 
insufficient o account for our findings. More direct 
evidence in favour of a carrier at the level of the 
plasma membrane is currently under investigation i
our laboratory. 
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